HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jonathan J Havel Selected Research

Immunotherapy

1/2021Qa-1b Modulates Resistance to Anti-PD-1 Immune Checkpoint Blockade in Tumors with Defects in Antigen Processing.
1/2019Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
1/2019Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.
1/2019The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy.
11/2017Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.
11/2016Recurrent SERPINB3 and SERPINB4 mutations in patients who respond to anti-CTLA4 immunotherapy.
10/2016The head and neck cancer immune landscape and its immunotherapeutic implications.
3/2015High-resolution genomic analysis: the tumor-immune interface comes into focus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jonathan J Havel Research Topics

Disease

14Neoplasms (Cancer)
08/2023 - 09/2008
2Lung Neoplasms (Lung Cancer)
11/2019 - 04/2015
2Melanoma (Melanoma, Malignant)
11/2017 - 11/2016
1Bites and Stings (Sting)
08/2023
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2019
1Turcot syndrome
01/2019
1Head and Neck Neoplasms (Head and Neck Cancer)
01/2019
1Microsatellite Instability
01/2019
1Salivary Gland Neoplasms (Salivary Gland Cancer)
10/2017
1Carcinoma (Carcinomatosis)
10/2017
1Squamous Cell Carcinoma of Head and Neck
10/2016
1Colorectal Neoplasms (Colorectal Cancer)
03/2015
1Prostatic Neoplasms (Prostate Cancer)
09/2008

Drug/Important Bio-Agent (IBA)

8Immune Checkpoint InhibitorsIBA
01/2021 - 04/2015
2AntigensIBA
01/2019 - 01/2018
1Interferon Type IIBA
08/2023
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
11/2019
1CTLA-4 AntigenIBA
01/2019
1AutoantigensIBA
01/2018
1NivolumabIBA
11/2017
1IpilimumabIBA
11/2017
15'-N-methylcarboxamideadenosineIBA
10/2017
1pembrolizumabIBA
04/2015
1VaccinesIBA
03/2015
1Prostate-Specific Antigen (Semenogelase)IBA
09/2008
1AntibodiesIBA
09/2008
1Androgen Receptors (Androgen Receptor)IBA
09/2008

Therapy/Procedure

8Immunotherapy
01/2021 - 03/2015
5Therapeutics
01/2019 - 04/2015